Abstract
GABAA receptors are involved in the subjective effects of alcohol. Endogenous neuroactive steroids interact with GABAA receptors to mediate several behavioral effects of alcohol in rodents. Based on a haplotypic association of alcohol dependence with the gene encoding the GABAA receptor α-2 subunit (GABRA2), we examined whether GABRA2 alleles are associated with the subjective response to alcohol. We also examined whether finasteride (a 5-α steroid reductase inhibitor), which blocks the synthesis of some neuroactive steroids, reduces the subjective response to alcohol. In all, 27 healthy social drinkers (15 males) completed a randomized, double-blind, placebo-controlled study of high-dose finasteride. After being pretreated with study drug, subjects consumed three alcoholic drinks. Subjective effects were measured repeatedly over the ascending blood alcohol curve. To examine the moderating role of genetic variation in GABRA2, a single-nucleotide polymorphism that was informative in association studies was included as a factor in the analysis. Subjects homozygous for the more common A-allele (n=7) showed more subjective effects of alcohol than did individuals with one or two copies of the alcohol dependence-associated G-allele (n=20, including two homozygotes). Among the A-allele homozygotes, there was a greater reduction in several subjective effects during the finasteride session compared to the placebo session. These findings provide preliminary evidence that the risk of alcoholism associated with GABRA2 alleles may be related to differences in the subjective response to alcohol. The effects of finasteride provide indirect evidence for a mediating role of neuroactive steroids in some of the subjective effects of alcohol.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
Balakleevsky A, Colombo G, Fadda F, Gessa GL (1990). Ro19-4603, a benzodiazepine inverse agonist, attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference. Alcohol Alcohol 25: 449–452.
Barbaccia ML, Affricano D, Trabucchi M, Purdy RH, Colombo G, Agabio R et al (1999). Ethanol markedly increases ‘GABAergic’ neurosteroids in alcohol-preferring rats. Eur J Pharmacol 384: R1–R2.
Bauer LO, Hesselbrock VM (1993). EEG, autonomic and subjective correlates of the risk for alcoholism. J Stud Alcohol 54: 577–589.
Boyle AE, Segal R, Smith BR, Amit Z (1993). Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacol Biochem Behav 46: 179–182.
Chester JA, Cunningham CL (2002). GABA(A) receptor modulation of the rewarding and aversive effects of ethanol. Alcohol 26: 131–143.
Chutuape MA, de Wit H (1994). Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend 34: 243–251.
Covault C, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR (2004). Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet 129B: 104–109.
Davies M (2003). The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci 28: 263–274.
de Wit H, Uhlenhuth EH, Johanson CE (1987). Individual differences in behavioral and subjective responses to alcohol. Alcohol Clin Exp Res 11: 52–59.
Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO et al (2004). Variations in GABRA2, encoding the alpha 2 subunit of the GABAA receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 74: 705–714.
Finn DA, Sinnott RS, Ford MM, Long SL, Tanchuck MA, Phillips TJ (2004). Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice. Neuroscience 123: 813–819.
First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV Axis I Disorders—Patient Edition (SCID—I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York.
Grobin AC, Matthews DB, Devaud LL, Morrow AL (1998). The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl) 139: 2–19.
Harris RA, Mihic SJ, Valenzuela CF (1998). Alcohol and benzodiazepines: recent mechanistic studies. Drug Alcohol Depend 51: 155–164.
Heath AC, Martin NG (1992). Genetic differences in psychomotor performance decrement after alcohol: a multivariate analysis. J Stud Alcohol 53: 262–271.
Holdstock L, de Wit H (1998). Individual differences in the biphasic effects of ethanol. Alcohol Clin Exp Res 22: 1903–1911.
Holdstock L, King AC, de Wit H (2000). Subjective and objective responses to ethanol in moderate/heavy and light social drinkers. Alcohol Clin Exp Res 24: 789–794.
Khisti RT, VanDoren MJ, O'Buckley T, Morrow AL (2003). Neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res 980: 255–265.
Koltchine VV, Finn SE, Jenkins A, Nikolaeva N, Lin A, Harrison NL (1999). Agonist gating and isoflurane potentiation in the human gamma-aminobutyric acid type A receptor determined by the volume of a second transmembrane domain residue. Mol Pharmacol 56: 1087–1093.
Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, Moore E et al (1998). Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an Am Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 81: 216–221.
Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA et al (2000). Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290: 131–134.
Maisto SA, Connors GJ, Tucker JA, McCollam JB (1980). Validation of the sensation scale, a measure of subjective physiological responses to alcohol. Behav Res Ther 18: 37–43.
Martin CS, Earleywire M, Musty RE, Perrine MW, Swift RM (1993). Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17: 140–146.
Martin NG (1988). Twin studies of alcohol consumption, metabolism and sensitivity. Aust Drug Alcohol Rev 7: 9–12.
Martin NG, Oakeshott JG, Gibson JB, Starmer GA, Perl J, Wilks AV (1985). A twin study of psychomotor and physiological responses to an acute dose of alcohol. Behav Genet 15: 305–347.
Mascia MP, Trudell JR, Harris RA (2000). Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. Proc Natl Acad Sci USA 97: 9305–9310.
McBride WJ, Murphy JM, Lumeng Land Li TK (1998). Effects of Ro15-4513, fluoxetine and desipramine on intake of ethanol water and food in alcohol preferring and non-preferring lines of rats. Pharmacol Biochem Behav 30: 1045–1050.
Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE et al (1997). Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389: 385–389.
Morrow AL, Janis GC, VanDoren MJ, Matthews DB, Samson HH, Jan PH et al (1999). Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of action? Alcohol Clin Exp Res 23: 1933–1940.
Morrow AL, VanDoren MJ, Penland SN, Matthews DB (2001). The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Brain Res Rev 37: 98–109.
Moss HB, Yao JK, Maddock JM (1989). Responses by sons of alcoholic fathers to alcoholic and placebo drinks: perceived mood, intoxication, and plasma prolactin. Alcohol Clin Exp Res 13: 252–257.
Newlin DB, Thompson JB (1990). Alcohol challenge with sons of alcoholics: a critical review analysis. Psychol Bull 108: 383–402.
Ohtawa M, Morikawa H, Shimazaki J (1991). Pharmacokinetic and biochemical efficacy after a single and multiple oral administration of N-(2methyl-2propyl)-3-oxo-4-aza-5-α-androst-1-ene-17-carboxamide, a new type of specific competitive inhibitor of testosterone 5-α-reductase, in volunteers. Eur J Drug Metab Pharmacokinet 16: 15–21.
O'Malley SS, Maisto SA (1985). Effects of family drinking history and expectancies on responses to alcohol in men. J Stud Alcohol 46: 289–297.
Petry NM (1997). Benzodiazepine–GABA modulation of concurrent ethanol and sucrose reinforcement in the rat. Exp Clin Psychopharmacol 5: 183–194.
Pohorecky LA, Brick J (1988). Pharmacology of ethanol. Pharmacol Ther 36: 335–427.
Poletti A, Negri-Cesi P, Rabuffetti M, Colciago A, Celotti F, Martini L (1998). Transient expression of the 5-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life. Endocrinology 139: 2171–2178.
Pollock VE (1992). Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics. Am J Psychiatry 149: 1534–1538.
Pollock VE, Teasdale TW, Gabrielli WF, Knop J (1986). Subjective and objective measures of response to alcohol among young men at risk for alcoholism. J Stud Alcohol 47: 297–304.
Rassnick S, D'Amico E, Riley E, Koob GF (1993). GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcohol Clin Exp Res 17: 124–130.
Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P et al (1998). Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 8: 207–215.
Romeo E, Brancati A, De Lorenzo A, Fucci P, Furnari C, Pompili E et al (1996). Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin Neuropharmacol 19: 366–369.
Romeo E, Pompili E, di Michele F, Pace M, Rupprecht R, Bernardi G et al (2000). Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J Biol Psychiatry 1: 101–104.
Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM et al (1999). Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401: 796–800.
Samson HH, Tolliver GA, Pfeffer AU, Sadeghi KG, Mills FG (1987). Oral ethanol reinforcement in the rat: effect of the partial inverse benzodiazepine agonist Ro15-4513. Pharmacol Biochem Behav 27: 517–519.
Sarkola T, Eriksson CJ (2003). Testosterone increases in men after a low dose of alcohol. Alcohol Clin Exp Res 27: 682–685.
Sarkola T, Fukunaga T, Makisalo H, Peter Eriksson CJ (2000). Acute effect of alcohol on androgens in premenopausal women. Alcohol Alcohol 35: 84–90.
Savoie TM, Emory EK, Moody-Thomas S (1988). Acute alcohol intoxication in socially drinking female and male offspring of alcoholic fathers. J Stud Alcohol 49: 430–435.
Schuckit MA (1984). Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry 41: 879–884.
Schuckit MA (1994). Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151: 184–189.
Schuckit MA, Smith TL, Kalmijn J, Tsuang J, Hesselbrock V, Bucholz K (2000). Response to alcohol in daughters of alcoholics: a pilot study and a comparison with sons of alcoholics. Alcohol Alcohol 35: 242–248.
Schuckit MA, Tsuang JW, Anthenelli RM, Tipp JE, Nurnberger Jr JI (1996). Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J Stud Alcohol 57: 368–377.
Smith BR, Robidoux J, Amit Z (1992). GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats. Alcohol Alcohol 27: 227–231.
Sobell LC, Sobell MD (1992). Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J (eds). Measuring Alcohol Consumption. Human Press: Clifton, NJ. pp 41–65.
Stoffel-Wagner B, Watzka M, Steckelbroeck S, Wickert L, Schramm J, Romalo G et al (1998). Expression of 5-reductase in the human temporal lobe of children and adults. J Clin Endocrinol Metab 83: 3636–3642.
Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994). Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151: 1463–1467.
Tauber M, Calame-Droz E, Prut L, Rudolph U, Crestani F (2003). Alpha2-gamma-aminobutyric acid (GABA)A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo. Eur J Neurosci 18: 2599–2604.
Tian G (1996). In vivo time-dependent inhibition of human steroid 5 alpha-reductase by finasteride. J Pharm Sci 85: 106–111.
Tian G, Stuart JD, Moss ML, Domanico PL, Bramson HN, Patel IR et al (1994). 17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1. Biochemistry 33: 2291–2296.
Tobler I, Kopp C, Deboer T, Rudolph U (2001). Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc Natl Acad Sci USA 98: 6464–6469.
Torres JM, Ortega E (2003). Alcohol intoxication increases allopregnanolone levels in female adolescent humans. Neuropsychopharmacology 28: 1207–1209.
Torres JM, Ortega E (2004). Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology (Berl) 172: 352–355.
Ueno S, Harris RA, Messing RO, Sanchez-Perez AM, Hodge CW, McMahon T et al (2001). Alcohol actions on GABA(A) receptors: from protein structure to mouse behavior. Alcohol Clin Exp Res 25: 76S–81S.
VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL (2000). Neuroactive steroid 3-alpha-hydroxy-5-alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci 20: 1982–1989.
Viken RJ, Rose RJ, Morzorati SL, Christian JC, Li TK (2003). Subjective intoxication in response to alcohol challenge: heritability and covariation with personality, breath alcohol level, and drinking history. Alcohol Clin Exp Res 27: 795–803.
Watson PE (1989). Total body water and blood alcohol levels: updating the fundamentals. In: Crow KE, Batt RD (eds). Human Metabolism of Alcohol. CRC Press: Boca Raton, FL. pp 41–56.
Acknowledgements
This study was supported by NIH Grants AA13736, AA07290, AA03510, and RR06192 (University of Connecticut General Clinical Research Center (GCRC)). Contributions by the staff of the Clinical Research and Evaluation Unit of the Alcohol Research Center and the GCRC are gratefully acknowledged. We also thank Lawrence Raisz and Joel Gelernter for their helpful review and comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pierucci-Lagha, A., Covault, J., Feinn, R. et al. GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride. Neuropsychopharmacol 30, 1193–1203 (2005). https://doi.org/10.1038/sj.npp.1300688
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300688
Keywords
This article is cited by
-
GABAA receptor polymorphisms in alcohol use disorder in the GWAS era
Psychopharmacology (2018)
-
Mechanisms in the relation between GABRA2 and adolescent externalizing problems
European Child & Adolescent Psychiatry (2016)
-
Ethanol Alters Local Cellular Levels of (3α,5α)-3-Hydroxypregnan-20-one (3α,5α-THP) Independent of the Adrenals in Subcortical Brain Regions
Neuropsychopharmacology (2014)
-
Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
Psychopharmacology (2014)
-
Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies
Psychopharmacology (2014)
